3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
31
Carcinoma, Renal Cell
19
Carcinoma, Non-Small-Cell Lung
19
Neoplasm Metastasis
11
Carcinoma, Hepatocellular
9
Brain Neoplasms
8
Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Pancreatic Neoplasms
5
Lung Neoplasms
5
Clear-cell metastatic renal cell carcinoma
5
Carcinoma, Transitional Cell
5
Uveal Melanoma
4
Skin Neoplasms
4
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Multiple Myeloma
4
Mesothelioma
4
Kidney Neoplasms
4
Glioblastoma
4
Carcinoma, Basal Cell
4
Carcinoma
4
Sarcoma
3
Recurrence
3
Myelodysplastic Syndromes
3
Liver Neoplasms
3
Leukemia, Myeloid, Acute
3
Gliosarcoma
3
Colorectal Neoplasms
3
Breast Neoplasms
3
Interventions
pembrolizumab
1
osimertinib
1
durvalumab
1
AZD 6244
1
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Non Small Cell Lung Cancer
×
Ipilimumab
×
90 days
×
Clear all
No trials found.